124 related articles for article (PubMed ID: 12901837)
1. PML nuclear bodies and neuronal intranuclear inclusion in polyglutamine diseases.
Takahashi J; Fujigasaki H; Iwabuchi K; Bruni AC; Uchihara T; El Hachimi KH; Stevanin G; Dürr A; Lebre AS; Trottier Y; de Thé H; Tanaka J; Hauw JJ; Duyckaerts C; Brice A
Neurobiol Dis; 2003 Aug; 13(3):230-7. PubMed ID: 12901837
[TBL] [Abstract][Full Text] [Related]
2. Promyelocytic leukemia protein is redistributed during the formation of intranuclear inclusions independent of polyglutamine expansion: an immunohistochemical study on Marinesco bodies.
Kumada S; Uchihara T; Hayashi M; Nakamura A; Kikuchi E; Mizutani T; Oda M
J Neuropathol Exp Neurol; 2002 Nov; 61(11):984-91. PubMed ID: 12430715
[TBL] [Abstract][Full Text] [Related]
3. Two populations of neuronal intranuclear inclusions in SCA7 differ in size and promyelocytic leukaemia protein content.
Takahashi J; Fujigasaki H; Zander C; El Hachimi KH; Stevanin G; Dürr A; Lebre AS; Yvert G; Trottier Y; de Thé H; Hauw JJ; Duyckaerts C; Brice A
Brain; 2002 Jul; 125(Pt 7):1534-43. PubMed ID: 12077003
[TBL] [Abstract][Full Text] [Related]
4. Interaction between neuronal intranuclear inclusions and promyelocytic leukemia protein nuclear and coiled bodies in CAG repeat diseases.
Yamada M; Sato T; Shimohata T; Hayashi S; Igarashi S; Tsuji S; Takahashi H
Am J Pathol; 2001 Nov; 159(5):1785-95. PubMed ID: 11696439
[TBL] [Abstract][Full Text] [Related]
5. Non-expanded polyglutamine proteins in intranuclear inclusions of hereditary ataxias--triple-labeling immunofluorescence study.
Uchihara T; Fujigasaki H; Koyano S; Nakamura A; Yagishita S; Iwabuchi K
Acta Neuropathol; 2001 Aug; 102(2):149-52. PubMed ID: 11563629
[TBL] [Abstract][Full Text] [Related]
6. SUMOylation substrates in neuronal intranuclear inclusion disease.
Takahashi-Fujigasaki J; Arai K; Funata N; Fujigasaki H
Neuropathol Appl Neurobiol; 2006 Feb; 32(1):92-100. PubMed ID: 16409557
[TBL] [Abstract][Full Text] [Related]
7. Intranuclear rodlets in the substantia nigra: interactions with marinesco bodies, ubiquitin, and promyelocytic leukemia protein.
Woulfe J; Gray D; Prichett-Pejic W; Munoz DG; Chretien M
J Neuropathol Exp Neurol; 2004 Nov; 63(11):1200-7. PubMed ID: 15581187
[TBL] [Abstract][Full Text] [Related]
8. Neuronal intranuclear inclusion disease without polyglutamine inclusions in a child.
McFadden K; Hamilton RL; Insalaco SJ; Lavine L; Al-Mateen M; Wang G; Wiley CA
J Neuropathol Exp Neurol; 2005 Jun; 64(6):545-52. PubMed ID: 15977647
[TBL] [Abstract][Full Text] [Related]
9. Progressive formation of inclusions in the striatum and hippocampus of mice transgenic for the human Huntington's disease mutation.
Morton AJ; Lagan MA; Skepper JN; Dunnett SB
J Neurocytol; 2000 Sep; 29(9):679-702. PubMed ID: 11353291
[TBL] [Abstract][Full Text] [Related]
10. A novel GTPase, CRAG, mediates promyelocytic leukemia protein-associated nuclear body formation and degradation of expanded polyglutamine protein.
Qin Q; Inatome R; Hotta A; Kojima M; Yamamura H; Hirai H; Yoshizawa T; Tanaka H; Fukami K; Yanagi S
J Cell Biol; 2006 Feb; 172(4):497-504. PubMed ID: 16461359
[TBL] [Abstract][Full Text] [Related]
11. Ataxin-3 is translocated into the nucleus for the formation of intranuclear inclusions in normal and Machado-Joseph disease brains.
Fujigasaki H; Uchihara T; Koyano S; Iwabuchi K; Yagishita S; Makifuchi T; Nakamura A; Ishida K; Toru S; Hirai S; Ishikawa K; Tanabe T; Mizusawa H
Exp Neurol; 2000 Oct; 165(2):248-56. PubMed ID: 10993685
[TBL] [Abstract][Full Text] [Related]
12. Promyelocytic leukemia nuclear bodies provide a scaffold for human polyomavirus JC replication and are disrupted after development of viral inclusions in progressive multifocal leukoencephalopathy.
Shishido-Hara Y; Higuchi K; Ohara S; Duyckaerts C; Hauw JJ; Uchihara T
J Neuropathol Exp Neurol; 2008 Apr; 67(4):299-308. PubMed ID: 18379438
[TBL] [Abstract][Full Text] [Related]
13. PML clastosomes prevent nuclear accumulation of mutant ataxin-7 and other polyglutamine proteins.
Janer A; Martin E; Muriel MP; Latouche M; Fujigasaki H; Ruberg M; Brice A; Trottier Y; Sittler A
J Cell Biol; 2006 Jul; 174(1):65-76. PubMed ID: 16818720
[TBL] [Abstract][Full Text] [Related]
14. Recruitment of nonexpanded polyglutamine proteins to intranuclear aggregates in neuronal intranuclear hyaline inclusion disease.
Takahashi J; Tanaka J; Arai K; Funata N; Hattori T; Fukuda T; Fujigasaki H; Uchihara T
J Neuropathol Exp Neurol; 2001 Apr; 60(4):369-76. PubMed ID: 11305872
[TBL] [Abstract][Full Text] [Related]
15. Stress responses of PML nuclear domains are ablated by ataxin-1 and other nucleoprotein inclusions.
Dovey CL; Varadaraj A; Wyllie AH; Rich T
J Pathol; 2004 Aug; 203(4):877-83. PubMed ID: 15258989
[TBL] [Abstract][Full Text] [Related]
16. The promyelocytic leukemia nuclear body: sites of activity?
Eskiw CH; Bazett-Jones DP
Biochem Cell Biol; 2002; 80(3):301-10. PubMed ID: 12123283
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional repression and cell death induced by nuclear aggregates of non-polyglutamine protein.
Fu L; Gao YS; Sztul E
Neurobiol Dis; 2005 Dec; 20(3):656-65. PubMed ID: 15964198
[TBL] [Abstract][Full Text] [Related]
18. Neuronal intranuclear hyaline inclusion disease.
Takahashi-Fujigasaki J
Neuropathology; 2003 Dec; 23(4):351-9. PubMed ID: 14719553
[TBL] [Abstract][Full Text] [Related]
19. Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro.
Chai Y; Koppenhafer SL; Shoesmith SJ; Perez MK; Paulson HL
Hum Mol Genet; 1999 Apr; 8(4):673-82. PubMed ID: 10072437
[TBL] [Abstract][Full Text] [Related]
20. SUMO-1 co-localized with mutant atrophin-1 with expanded polyglutamines accelerates intranuclear aggregation and cell death.
Terashima T; Kawai H; Fujitani M; Maeda K; Yasuda H
Neuroreport; 2002 Dec; 13(17):2359-64. PubMed ID: 12488827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
